Cipla Usa Drug Patent Portfolio

Cipla Usa owns 1 orange book drug protected by 4 US patents Given below is the list of Cipla Usa's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8383596 Antibacterial aminoglycoside analogs 02 Jun, 2031
Active
US8822424 Antibacterial aminoglycoside analogs 21 Nov, 2028
Active
US9266919 Antibacterial aminoglycoside analogs 21 Nov, 2028
Active
US9688711 Antibacterial aminoglycoside analogs 21 Nov, 2028
Active


Given below is the list of recent legal activities going on the following drug patents of Cipla Usa.

Activity Date Patent Number
Patent litigations
FDA Final Eligibility Letter 30 Jan, 2024 US8822424
FDA Final Eligibility Letter 30 Jan, 2024 US8383596
Payment of Maintenance Fee, 8th Yr, Small Entity 23 Aug, 2023 US9266919
transaction for FDA Determination of Regulatory Review Period 15 May, 2023 US8383596
transaction for FDA Determination of Regulatory Review Period 15 May, 2023 US8822424
transaction for FDA Determination of Regulatory Review Period 18 Apr, 2023 US8383596
transaction for FDA Determination of Regulatory Review Period 18 Apr, 2023 US8822424
Payment of Maintenance Fee, 8th Yr, Small Entity 02 Mar, 2022 US8822424
Payment of Maintenance Fee, 4th Yr, Small Entity 28 Dec, 2020 US9688711
Second letter to regulating agency to determine regulatory review period 24 Sep, 2020 US8822424
Second letter to regulating agency to determine regulatory review period 24 Sep, 2020 US8383596
7.5 yr surcharge - late pmt w/in 6 mo, Small Entity 28 Aug, 2020 US8383596
Payment of Maintenance Fee, 8th Yr, Small Entity 28 Aug, 2020 US8383596
Email Notification 14 May, 2020 US8822424
Change in Power of Attorney (May Include Associate POA) 14 May, 2020 US8383596


Cipla Usa's Family Patents

Cipla Usa drugs have patent protection in a total of 21 countries. It's US patent count contributes only to 32.4% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Cipla Usa Drug List

Given below is the complete list of Cipla Usa's drugs and the patents protecting them.


1. Zemdri

Zemdri is protected by 4 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8383596 Antibacterial aminoglycoside analogs 02 Jun, 2031
(6 years from now)
Active
US8822424 Antibacterial aminoglycoside analogs 21 Nov, 2028
(3 years from now)
Active
US9266919 Antibacterial aminoglycoside analogs 21 Nov, 2028
(3 years from now)
Active
US9688711 Antibacterial aminoglycoside analogs 21 Nov, 2028
(3 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zemdri's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List